Patents by Inventor K. Jin Kim

K. Jin Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
    Publication number: 20100136624
    Abstract: A method of making monoclonal antibodies according to a mixed antigen immunization protocol is described. In addition, antibodies obtainable by the method are disclosed which specifically cross-react with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind.
    Type: Application
    Filed: July 30, 2009
    Publication date: June 3, 2010
    Applicant: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Anan Chuntharapai, K. Jin Kim
  • Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
    Patent number: 7592439
    Abstract: A method of making monoclonal antibodies according to a mixed antigen immunization protocol is described. In addition, antibodies obtainable by the method are disclosed which specifically cross-react with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: September 22, 2009
    Assignee: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Anan Chuntharapai, K. Jin Kim
  • Method for making monoclonal antibodies and cross-reactive antibodies obtainanble by the method
    Publication number: 20080176286
    Abstract: A method of making monoclonal antibodies according to a mixed antigen immunization protocol is described. In addition, antibodies obtainable by the method are disclosed which specifically cross-react with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind.
    Type: Application
    Filed: April 24, 2007
    Publication date: July 24, 2008
    Applicant: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Anan Chuntharapai, K. Jin Kim
  • Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
    Publication number: 20020004227
    Abstract: A method of making monoclonal antibodies according to a mixed antigen immunization protocol is described. In addition, antibodies obtainable by the method are disclosed which specifically cross-react with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind.
    Type: Application
    Filed: April 9, 2001
    Publication date: January 10, 2002
    Applicant: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Anan Chuntharapai, K. Jin Kim
  • Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
    Patent number: 6252050
    Abstract: A method of making monoclonal antibodies according to a mixed antigen immunization protocol is described. In addition, antibodies obtainable by the method are disclosed which specifically cross-react with two or more different receptors to which Apo-2 ligand (Apo-2L) can bind.
    Type: Grant
    Filed: June 10, 1999
    Date of Patent: June 26, 2001
    Assignee: Genentech, Inc.
    Inventors: Avi J. Ashkenazi, Anan Chuntharapai, K. Jin Kim
  • Antibodies to PF4A receptor
    Patent number: 5874543
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: February 23, 1999
    Assignee: Genetech, Inc.
    Inventors: Anan Chuntharapai, James Lee, Caroline Hebert, K. Jin Kim
  • Antibodies to a human PF4 superfamily receptor
    Patent number: 5840856
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: August 10, 1994
    Date of Patent: November 24, 1998
    Assignee: Genentech, Inc.
    Inventors: Anan Chuntharapai, James Lee, Caroline Hebert, K. Jin Kim
  • Antibodies to human IL-8 type A receptor
    Patent number: 5543503
    Abstract: cDNAs encoding a class of receptors, including the IL-8 receptors, have been identified in human tissue. Recombinantly produced PF4ARs are used in the preparation and purification of antibodies capable of binding to the receptors, and in diagnostic assays. The antibodies are advantageously used in the prevention and treatment of inflammatory conditions.
    Type: Grant
    Filed: June 11, 1993
    Date of Patent: August 6, 1996
    Assignee: Genentech Inc.
    Inventors: Anan Chuntharapai, James Lee, Caroline Hebert, K. Jin Kim